32 - Antifungal Drugs (Quelle) Flashcards
(45 cards)
most common type of mucocutaneous oral and genital fugal infection
candidiasis
fungus most often associated with oral lesions (thrush, denture stomatitis)
candida albicans
2 categories of antifungal drugs
systemic infections-oral and parenteral
superficial and mucocutaneous infections-topical and oral
polyene antibiotics
amphotericin B and nystatin
amphotericin B drug of choice for what
broadest spectrum
most life threatening systemic fungal infections
amphotericin b cidal or static
cidal
mechanism of amphotericin b
binds to ergosterol (cell membrane)
makes pore-alters permeability
leakage of Na, K, H
cell death-cidal
selective toxicity of amphotericin b
mammalian cell membranes have cholesterol
fungal resistance of amphotericin b
when binding of drug to ergosterol is impaired
- decreased ergosterol concentration from azoles
- ergosteroles affinity is reduced
- rare but seen in candida species
amphotericin b pharmacokinetics
poorly absorbed from GI and skin-topically for candida
used parenterally for systemic infections
slow IV infusion
metabolism of amphotericin b
kidney
adverse effects of amphotericin b
topical-local irritation
immediate reaction-fever, chills, muscle spasm, vomiting, headache, hypotension, allergic reaction : slow dose or decrease dose
nephrotoxicity
most important side effect of amphotericin b
nephrotoxicity
drug interactions with amphotericin b
digitalis- induced hypokalemia
azoles-inhibitors of ergosterol synthesis, amphtericin b resistance
Nephrotoxic agents
nystatin use
similar to amphotericin b
narrower spectrum
too toxic for parenteral use
not well absorbed
nystatin pharmacokinetics
topically for candidal infections of mucosa, skin, GI, vagina
**THRUSH
nystatin adverse effects
bitter taste
griseofulvin mechanism
interacts with microtubules to block fungal mitosis
griseofulvin use
fungistatic
oral
treatment of dermatophytosis (hair, skin, nails)
griseofulvin adverse effects
induces CYP isoforms
alters pharmacologic effectiveness of drugs
flucytosine mechanisms
enzyme cytosine deaminase converts it to 5-fu
inhibits fungal DNA and protein synthesis
flucytosine uses
orally
candida and cryptococcus
fungistatic
selective toxicity of flucytosine
human cells cant convert to 5-fu
flucytosine must be used with
amphotericin b